The IPO Buzz: Electra Therapeutics (ETRA) Upsizes IPO & Prices it at $15 – Mid-Point
Electra Therapeutics (ETRA) upsized its IPO at pricing to 23.33 million shares – up from 21.67 million shares in the prospectus – and priced the IPO at $15.00 – the mid-point of its $14.00-to-$16.00 range – to raise $349.95 million on Thursday night, Sept. 17, 2026. Electra Therapeutics’ IPO rode the wave of strong demand from biotech and healthcare investors. Biotech IPOs have done ..
Read more September 17, 2026IPO Calendar
| Company | Symbol proposed | Shares (Millions) | Est. $ Volume | Expected to Trade | SCOOP Rating | Rating Change |
|---|---|---|---|---|---|---|
| Electra Therapeutics | ETRA | 23.3 | $ 350.0 mil | 9/18/2026 Priced | S/O | S/O |
| Leader’s Advantage Acquisition Corp. | LEDRU | 15.0 | $ 150.0 mil | 9/18/2026 Priced | S/O | S/O |
| Orion180 Insurance Group | OIG | 20.0 | $ 240.0 mil | 9/18/2026 Priced | S/O | S/O |
Last 100 IPOs - September 17, 2026
| Number of IPOs priced : | 100 |
| Number Up: | 49 |
| Number Down: | 50 |
| Number Unchanged: | 1 |
| Percentage Change From Issue Price: | 8.06% |
| Percentage Change for The Nasdaq Composite | 35.22% |
2026 IPO Scorecard - September 17, 2026
| Number of IPOs priced (Excluding 146 units) : | 121 |
| Number Up: | 59 |
| Number Down: | 61 |
| Number Unchanged: | 1 |
| Total Return From Issue Price: | 8.09% |
| The Nasdaq Composite Index YTD % Change | 35.22% |